🇺🇸 FDA
Pipeline program

Tranexamic Acid 1000 mg/10ml normal saline infusion

NMCSD.2017.0034

Approved small_molecule terminated

Quick answer

Tranexamic Acid 1000 mg/10ml normal saline infusion for Postpartum Hemorrhage is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Postpartum Hemorrhage
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials